Shire to Enter European ADHD Market

By Taskin Ahmed

Pharma Deals Review: Vol 2009 Issue 2 (Table of Contents)

Published: 20 Feb-2009

DOI: 10.3833/pdr.v2009.i2.82     ISSN: 1756-7874

Section: Licensing

Fulltext:

Abstract

Shire has acquired the worldwide rights excluding US, Canada and Barbados for Equasym® IR and XL from UCB...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details